Merck & Co. ditches oncolytic virus Cavatak 4 years after buying Viralytics - FierceBiotech

Submitted by Anonymous (not verified) on Thu, 10/27/2022 - 14:54

Merck & Co. ditches oncolytic virus Cavatak 4 years after buying Viralytics  FierceBiotech